4.29.2025
New Jersey Law Journal (reprinted with permission)
In their newest publication, Michael F. Schaff and Jennie M. Miller explore the New Jersey Cannabis Regulatory Commission’s adoption of updated cannabis testing guidelines. They outline the evolution of testing standards from interim measures in 2021 to the newly implemented framework, which features smaller batch sizes, expanded contaminant screening, and more detailed cannabinoid labeling. The article highlights the NJ-CRC’s focus on public health, safety, and transparency, while also noting the ongoing complexity of navigating state and federal cannabis laws.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.
Michael F. Schaff
Co-Chair, Corporate, Health and Cannabis Law Teams
Shareholder
732.855.6047
Jennie M. Miller
Associate
732.855.6179
